dihexa pnb-0408 c-met hgfr activator (PNB-0408) | C27H44N4O5 | CID 125355097 MET – an ideal target
MET an ideal target for antibody drug conjugate therapy, plus nivolumab Cancer Biology Activated HGF c Met Axis in Head and Neck Cancer dihexa pnb 0408 c met hgfr activator Small molecule activation of the neurotrophin hepatocyte growth factor to treat Alzheimer disease Dihexa (PNB 0408) c Met HGFR Activator Pancreatic Cancer Treatment Targeting the HGF c MET Pathway: The MEK Inhibitor Trametinib
Pay in 4 interest-free payments of $5.80 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5



